|
|
|
|
More About
|
|
Our Leadership & Experience
|
|
|
|
|
TrialAdvance combines thought leadership with pragmatic site solutions generated through years of experience to provide clients with more predictable, faster clinical trials. |
|
|
|
|
Consolidating Knowledge and Experience |
|
|
|
|
Kathleen leads a team of industry veterans who have managed study programs for the biopharmaceutical industry; managed operations at investigative sites; and implemented large, centralized recruitment campaigns on the media side. Her team has worked on landmark clinical trials and patient registries across a wide range of therapeutic areas and special patient populations. |
|
|
Kathleen B. Drennan
CEO and President
(more about Kathleen)
|
|
TrialAdvance also has strategic partnerships with leaders in the fields of investigative site selection, multicultural communications, and site operations. |
|
Seasoned Leadership With a Unique Perspective |
|
TrialAdvance President Kathleen Drennan brings an exceptional skill set to our clients. She is a rare industry veteran who has had a direct impact on the various “worlds” of clinical research — the biopharmaceutical industry, academia, and the actual business of clinical trials. |
|
|
|
|
|
|
Biopharmaceutical: |
Cardiovascular clinical trial specialist at the Upjohn Company for 11 years |
|
|
Academia: |
President, COO, & cofounder of the Chicago Center for Clinical Research (CCCR) at Rush-Presybterian-St Luke's Medical Center, the largest and most successful independent research organization of its time |
|
|
Clinical Trial Services: |
SVP & managing director of IRIS Global Clinical Trial Solutions, a patient- recruitment and site-communications agency |
|
|
|
|
|
With so much hands-on experience, Kathleen knows what it takes to recruit and enroll thousands of qualified patients. She understands the satisfaction and frustrations experienced by sponsor teams and site staff alike
|
|
|
|
